A phase I trial of the monoclonal antibody FG-3019 to connective tissue growth factor (CTGF) in locally advanced or metastatic pancreatic cancer.
Year: 2011
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: G. M. Heestand, J. M. Pipas, F. Valone, A. D. McMullen, P. Gadea, D. Williams, M. Zhong, T. Neff, G. A. Fisher, A. Koong
Institutions: Dartmouth–Hitchcock Medical Center, Stanford Medicine
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2590523099
